A detailed history of Pro Share Advisors LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 28,055 shares of DVAX stock, worth $309,166. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,055
Previous 35,269 20.45%
Holding current value
$309,166
Previous $437,000 27.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.73 - $12.58 $77,406 - $90,752
-7,214 Reduced 20.45%
28,055 $315,000
Q1 2024

May 08, 2024

BUY
$11.7 - $14.98 $31,484 - $40,311
2,691 Added 8.26%
35,269 $437,000
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $168,507 - $192,837
12,873 Added 65.33%
32,578 $455,000
Q3 2023

Nov 13, 2023

SELL
$12.64 - $14.99 $3,450 - $4,092
-273 Reduced 1.37%
19,705 $291,000
Q2 2023

Aug 10, 2023

BUY
$9.85 - $13.17 $26,319 - $35,190
2,672 Added 15.44%
19,978 $258,000
Q1 2023

May 11, 2023

SELL
$9.44 - $11.88 $14,480 - $18,223
-1,534 Reduced 8.14%
17,306 $169,000
Q4 2022

Feb 02, 2023

BUY
$10.27 - $13.29 $26,609 - $34,434
2,591 Added 15.95%
18,840 $200,000
Q3 2022

Nov 04, 2022

SELL
$9.93 - $17.44 $4,120 - $7,237
-415 Reduced 2.49%
16,249 $170,000
Q2 2022

Aug 01, 2022

SELL
$7.45 - $12.83 $26,454 - $45,559
-3,551 Reduced 17.57%
16,664 $210,000
Q1 2022

May 10, 2022

SELL
$9.75 - $14.44 $32,574 - $48,244
-3,341 Reduced 14.18%
20,215 $219,000
Q4 2021

Feb 08, 2022

BUY
$13.17 - $20.94 $128,367 - $204,102
9,747 Added 70.58%
23,556 $332,000
Q3 2021

Nov 12, 2021

SELL
$9.16 - $19.83 $129,705 - $280,792
-14,160 Reduced 50.63%
13,809 $265,000
Q2 2021

Aug 13, 2021

SELL
$7.25 - $10.99 $2,878 - $4,363
-397 Reduced 1.4%
27,969 $275,000
Q1 2021

May 14, 2021

BUY
$4.57 - $11.18 $22,063 - $53,977
4,828 Added 20.51%
28,366 $279,000
Q4 2020

Feb 09, 2021

BUY
$3.73 - $5.6 $39,224 - $58,889
10,516 Added 80.76%
23,538 $105,000
Q3 2020

Nov 13, 2020

BUY
$4.32 - $11.7 $3,745 - $10,143
867 Added 7.13%
13,022 $56,000
Q2 2020

Aug 03, 2020

BUY
$2.94 - $9.1 $35,735 - $110,610
12,155 New
12,155 $108,000
Q1 2020

May 15, 2020

SELL
$2.27 - $6.2 $25,646 - $70,047
-11,298 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$3.46 - $6.93 $39,091 - $78,295
11,298 New
11,298 $65,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.39B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.